A SUBSTITUTED PYRIMIDINE AS A PROSTAGLANDIN D2 RECEPTOR ANTAGONIST

The present invention is directed to a 2,6-substituted-4-monosubstitutedamino-pyrinudine compound of formula (I) as set forth herein, or an enantiomer thereof, or an ester prodrug or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising such a compound. The invention...

Full description

Saved in:
Bibliographic Details
Main Authors STOKLOSA, GREGORY T, AGUIAR, JOACY C, SHUM, PATRICK WAI-KWOK, POLI, GREGORY B, ZHAO, ZHICHENG, HARRIS, KEITH JOHN, CHOI-SLEDESKI, YONG-MI, REILING, STEPHAN
Format Patent
LanguageEnglish
Published 30.10.2012
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to a 2,6-substituted-4-monosubstitutedamino-pyrinudine compound of formula (I) as set forth herein, or an enantiomer thereof, or an ester prodrug or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising such a compound. The invention also includes a method of treatment of a patient by the administration of a pharmaceutically effective amount of such a compound.
Bibliography:Application Number: SG20120063897